MV-NIS infected mesenchymal stem cells
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for MV-NIS infected mesenchymal stem cells, covering 2025-07-16 to 2025-07-16. Get the full timeline:
Most recent: Clinical Trial Update: MV-NIS Infected Mesenchymal Stem Cells in Treating Recurrent Ovarian, Primary Peritoneal or Fallopian Tube Cancer [Phase 1, Phase 2]